decisionhealth Newsletters, Coder Pink Sheets - 2005 Issue 5 (May)
You may not know it, but . . .
Subscribe or sign in to view the full article.
Article Overview
This article explains a Medicare-focused distinction between screening and diagnostic fecal occult blood testing and notes how private payers may differ under CPT-oriented rules. It is useful for coders, billers, and compliance staff who need to understand coverage context, age and frequency limits, and the Medicare guidance cited in the article.
Why This Topic Matters
Correct reporting of fecal occult blood testing affects whether services are considered screening or diagnostic, whether Medicare coverage criteria are met, and how claims are handled by different payers.
What You Will Learn
- How the article distinguishes Medicare screening testing from diagnostic testing.
- Which general coverage and frequency themes are discussed for Medicare beneficiaries.
- How private payer handling is described in relation to CPT guidance.
- What Medicare manual references are mentioned in connection with the topic.
Who Should Read This
- Medical coders
- Billing specialists
- Compliance staff
- Revenue cycle professionals
- Primary care practices
- Gastroenterology practices
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com